Meeting presentation: Pilot data presented as a poster: "Colonoscopy without sedation: is it feasible?" at European Colorectal Congress, St. Gallen, Switzerland, 26 -- 29^th^ November 2012. Final data given as an oral short paper presentation: "Sedationless colonoscopy: Is there any difference in polyp detection and caecal intubation?" at the International Surgical Congress of the Association of Surgeons of Great Britain and Ireland (ASGBI), Glasgow UK on 1^st^-3^rd^ May 2013.

Introduction
============

Colonoscopy is the most common investigation for colonic pathology. In the UK it has become more frequent since the introduction of national bowel cancer screening programs, with 36,460 procedures performed in the first 3 years after their establishment [@JR186-1]. To maximize efficacy in both screening and non-screening cases, it must be performed accurately and under conditions acceptable to the patient.

Sedation traditionally has been used to minimize technical difficulties [@JR186-2] and studies demonstrate improved cecal intubation rates with it [@JR186-3] and reduced patient anxiety about subsequent colonoscopy [@JR186-4]. Sedation is not without risk as fewer than 1 % of patients experience cardiovascular problems and respiratory distress is seen in up to 8 of every 1000 patients undergoing the procedure [@JR186-5]. Sedation also places social and functional demands upon patients and, depending on the hospital's protocol, may require dedicated recovery time and an escort on discharge [@OR186-6]. A study of screening colonoscopy at a university center reported a median of 20 minutes for the procedure and 21 hours for preparation, travel, and recovery [@JR186-7]. Recently, sedation was found to have no effect on polyp or adenoma detection rate [@JR186-3] while sedation-less procedures may reduce the cecal intubation rate [@JR186-8], most likely from the discomfort associated with air insufflation [@JR186-9]. However, pain may not be a limiting factor for intubation rates as Petrini et al. showed that of the patients offered sedation on demand, 81 % underwent complete procedures without a sedative [@JR186-10].

The aim of this study is to compare the level of discomfort in patients who underwent non-sedated colonoscopies (NSC) to those with sedation (SC), and to determine the effect on polyp detection and cecal intubation rates. We also assessed the effects of anaesthetic risk, indications, endoscopists, and pathology on outcomes.

Patients and methods
====================

The prospectively accrued database (Unisoft^®^) of all colonoscopies performed at three district general hospitals in the UK between July 2011 and July 2012 was retrospectively analyzed. Sedation was routinely offered to all patients, however, 194 declined all medication. Throughout the procedure, patient comfort scores were obtained by two independent nurses using modified Glasgow comfort score descriptors, as outlined by the NHS Bowel Cancer Screening Programme (England, UK) [@OR186-11] ([Table 1](#TB186-1){ref-type="table"}). Staff at the three units are certified by the Joint Advisory Group on GI Endoscopy (JAG, UK). They performed colonoscopies in accordance with JAG's guidelines for bowel preparation, peri-procedure care, and recovery. Anaesthetic risk was assessed using the American Society of Anesthesiologists physical status classification system (ASA grade, [Table 2](#TB186-2){ref-type="table"}). Details of age, sex, ASA grade, comfort scores, complications, cecal intubation rate and polyp detection rates were obtained. An adjusted cecal intubation rate was calculated by including patient discomfort and excluding poor bowel preparation and instrument inadequacy. Statistical analysis was performed using Chi-squared test, Student's *t*-test or Mann-Whitney, univariate analysis for odds ratios and a *P* value less than 0.05 was considered significant.

###### Modified Glasgow Comfort Score descriptors.

  Descriptor   Definition
  ------------ ----------------------------------------------------------------------------
  No           No discomfort, resting comfortably throughout
  Minimal      One or two episodes of mild discomfort, well tolerated
  Mild         More than two episodes of discomfort, adequately tolerated
  Moderate     Significant discomfort, experienced several times throughout the procedure
  Severe       Extreme discomfort, experienced frequently during the procedure

###### American Society of Anesthesiologists physical status classification system (ASA grade)

  Classification   Definition
  ---------------- --------------------------------------------------------------------------
  ASA I            A normal healthy patient
  ASA II           A patient with mild systemic disease
  ASA III          A patient with severe systemic disease
  ASA IV           A patient with severe systemic disease that is a constant threat to life
  ASA V            A moribund patient who is not expected to survive without the operation

Results
=======

A total of 1694 colonoscopies were performed over a year, of which 194 were without sedation (11 %). [Table 3](#TB186-3){ref-type="table"} summarizes the key findings for both SC and NSC patients. In both groups colonoscopies were completed within similar time frames (*P = *0.590). There was a male predominance in the NSC group (male to female ratio 1.6:1), which was not demonstrated in the SC group (1:1.2 *P \< *0.001). There was no gender difference in discomfort levels (*P = *0.102). A single endoscopy unit carried out more colonoscopies without sedation than others within the organization (Hospital A, *P \< *0.0001). However, after excluding those who performed less than 100 cases (none of whom carried out NSCs), there were no differences in the numbers or rates of incomplete colonoscopies performed by the 10 high-volume endoscopists (*P = *0.105). A greater proportion of patients were referred for bleeding (*P* = 0.034) or frequency of stool (*P* = 0.036), while fewer were likely to have anaemia (*P = *0.014). All ASA grades were represented in both groups but there were more grade 3 patients in the NSC group (*P = *0.0003). A greater proportion experienced lower levels of discomfort (no discomfort 43 %, minimal 29 %, 13 % mild discomfort, *P \< *0.001). Macroscopic inflammation was associated with more moderate and severe discomfort across both groups. There were a comparable number of complications; three cases of mechanical damage to scope and two cases of haemorrhage occurred in the sedated group. There were no sedation-related complications noted. After multivariate analysis, a higher ASA grade correlated to NSC (p,0.001).

###### Analysis of patients undergoing colonoscopy with and without sedation.

  Factor                                                            Sedation (SC) n = 1500   No Sedation (NSC) n = 194   OR \[CI\]   *P* value                                 
  ---------------------------------------------- ------------------ ------------------------ --------------------------- ----------- -------------------- -------------------- ------------
  Age (years)                                                         64 (14)                 63 (15)                    --          0.283                                     
  Time taken (minutes)                             29 (13)           32 (18)                 --                          0.590                                                 
  Sex                                            Male                694 (46)                119 (61)                                \< 0.001                                  
                                                 Female              806 (54)                 75 (39)                                                                          
                                                                    Number                   \%                          Number      \%                                        
  Referral                                       Routine             922                     62                          101         52                   --                   0.026
                                                 Urgent              558                     37                           88         45                                        
                                                 Unknown              20                      1                            5          3                                        
  Hospital                                       A                   539                     36                           96         49                   --                    \< 0.0001
                                                 B                   491                     33                           63         33                                        
                                                 C                   470                     31                           35         18                                        
  ASA                                            1                   438                     29                           28         14                   --                   0.0003
                                                 2                   448                     30                           56         29                                        
                                                 3                   478                     32                           85         44                                        
                                                 4                   113                      8                           22         11                                        
                                                 Unknown              23                      1                            3          2                                        
  Therapeutic                                     385               26                        40                         21          0.8 \[0.5 -- 1.1\]   0.128                
  Inpatient                                                          673                     45                           84         43                   0.9 \[0.7 -- 1.3\]   0.680
  Screening                                                           31                     21                            7          4                   1.8 \[0.8 -- 4.1\]   0.178
  Surveillance                                    161               11                        22                         11          1.1 \[0.7 -- 1.7\]   0.798                
  Indication[1](#FN186-1){ref-type="table-fn"}   Bleeding            317                     21                           54         28                   1.4 \[1.0 -- 2.0\]   0.034
                                                 Anemia              125                      8                            6          3                   0.4 \[0.2 -- 0.8\]   0.014
                                                 CIBH                297                     20                           51         26                   1.4 \[1.0 -- 2.0\]   0.036
  Previous Resection(s)                            45                3                         9                          5          1.6 \[0.8 -- 3.3\]   0.225                
  Pathology[2](#FN186-2){ref-type="table-fn"}    Polyps              351                     23                           51         26                   1.2 \[0.9 -- 1.7\]   0.249
                                                 Inflammation        115                      8                            6          3                   0.4 \[0.2 -- 0.9\]   0.025
  Done by 2nd endoscopist                         217               15                        29                         15          1.0 \[0.7 -- 1.6\]   0.858                
  Failed cecal intubation                         153               10                        22                         11          1.1 \[0.7 -- 1.8\]   0.624                
  Adjusted cecal intubation                      1391               93                       185                         95          1.6 \[0.8 -- 3.2\]   0.180                
  Discomfort                                     None                521                     35                           84         43                   --                   \< 0.001
                                                 Minimal             529                     35                           57         29                                        
                                                 Mild                269                     18                           25         13                                        
                                                 Moderate            150                     10                            9          5                                        
                                                 Severe                0                      0                            0          0                                        
                                                 Unrecorded           31                      2                           19         10                                        
  Complications                                    30                2                         2                          1          --                   0.351                
                                                 Poorly tolerated     25                                                   2                                                   
                                                 Damaged scope         3                                                   0                                                   
                                                 Bleeding              2                                                   0                                                   

Age and time expressed as average (standard deviation). Significant values were *P* \< 0.05, derived by Chi-square test, t-test or Mann-Whitney. Odds ratio were obtained by univariate analysis.

CIBH: change in bowel habit

Only indications with significant *P* values are shown

No significant differences were found for diverticular disease, strictures or radiation proctitis.

Polyps were found in 51 out of 194 NSC patients (26 %) and comparable to the SC group (23 % *P = *0.249). The rates of failed cecal intubation were also similar at 11 % and 10 % respectively (*P = *0.624). Incomplete colonoscopies in the NSC group were due to inadequate bowel preparation, angulation or fixity of the distal sigmoid, instrument inadequacy, and, in three cases, patient discomfort; the adjusted cecal intubation rate was 95.4 % ([Table 4](#TB186-4){ref-type="table"}).

###### Depth of insertion of scope and reasons for failed cecal intubation in NSC patients.

  Depth of Insertion         Total   Reason for Failed Intubation (n)
  -------------------------- ------- ---------------------------------------------------------------------------------
  Cecum                      115     
  Terminal ileum/neo TI       57     
  Anastomosis                  1     
  Proximal ascending           1     Inadequate bowel prep
  Hepatic flexure              2     Discomfort (1) Bowel redundancy (1)
  Mid transverse               3     Inadequate bowel prep (2) Discomfort (1)
  Splenic flexure              3     Bowel prep (1) Instrument inadequacy (2) Excess looping (1)
  Proximal descending          2     Inadequate bowel prep (2)
  Distal sigmoid               5     Discomfort (1) Limited by angulation/fixed sigmoid (3)Inadequate bowel prep (1)
  Rectum                       3     Inadequate bowel prep (2) Solid stool obstructing lumen (1)
  55 cm                        1     Not recorded
  Total completed            173     
  Intubation rate             89 %   
  Adjusted intubation rate    95 %   Allowing for inadequate bowel prep and instrument inadequacy

Discussion
==========

When compared to SC, NSC offers patients a safe investigation with shorter recovery time without the assistance of an escort and with return to normal daily activities afterwards. Anecdotally, NSC facilitates better communication between the endoscopist and the patient, which may assist in positional changes towards successful completion. In our study, all patients were offered sedation at the start, and if they refused, it was offered again if these patients experienced discomfort during the procedure. From our data, we could not determine why patients did not want sedation or why some patients who started without sedation required that treatment when difficulty was encountered.

Of the 194 NSC patients, there was a male predominance. While colorectal adenoma is more prevalent in men [@JR186-12], polyp detection rates were similar in both SC and NSC patients. Arguably this may suggest under-detection of polyps, but that is less likely because the procedures were performed by JAG-accredited and experienced screening endoscopists. A larger study may be needed to further address this issue. In addition, we included patients referred via the suspected cancer or screening pathways, who may have a higher risk for colorectal neoplasia, but a risk adjusted analysis of these factors requires a larger study.

As the level of discomfort experienced by patients was recorded at three sites within a single organization, interobserver variability could have affected perception of patient discomfort. However, all units are certified by JAG and follow standard protocol for all procedures for recording discomfort. While endoscopist experience is known to affect polyp detection rates [@JR186-13] [@JR186-14], it was not controlled for in our study. Because all endoscopists were JAG accredited, it ensured that their skill levels were equal, and therefore, unlikely to influence outcomes.

Multivariate analysis of our results revealed that patients undergoing NSC were more likely to have more comorbidities as evidenced by higher ASA grades. NSC would certainly be a safer option given the risk that sedation poses to cardiovascular stability. We could not determine whether NSC was a patient's or endoscopist's choice, but exploring their motivations might help identify factors that could improve its uptake. We also demonstrated that some hospital units were more likely to use NSC than others, but the decision was not influenced by the endoscopist performing the procedure. Hospital factors that may affect decisions for NSC, such as outcome targets, patient information, informed consent, staff preferences and biases, warrant investigation even though they are likely to vary from one institution to another.

Previous studies have highlighted how discomfort may limit the completion of the procedure, and advocated the benefits of water insufflation [@JR186-15], sedation on demand (patient controlled), and sedation as needed (endoscopist controlled) [@JR186-16]. Overall, we showed that NSC can be completed comfortably with minimal variation in technique, supporting previous findings of success more so in men, and that it had no effect on polyp detection rate [@JR186-3]. Most patients tolerated the procedure well, with either no or minimal discomfort. Successful NSC is less likely with macroscopic inflammation as it was associated with significant discomfort.

Our cecal intubation rate matched that of previous studies [@JR186-8] and was similar to that achieved when sedation was used. The adjusted cecal intubation rate was 95.4 %, which satisfies the standard set by the NHS Bowel Cancer Screening Programme [@OR186-11]. In addition, polyp detection rates were comparable with both SC and NSC. That suggests that NSC with optimal bowel preparation and adequate instrumentation may achieve the high technical standards required by the screening program. It may also appeal to patients without an escort who are candidates for same-day discharge. A recent study showed that 56.2 % of 964 patients were willing to undergo NSC, and that fear of procedure-related pain was inversely related to procedure acceptance [@JR186-17]. As moderate discomfort was described in only 5 % of cases, our study promotes NSC, or at least sedation on demand, although it critically lacked a post-procedure survey of patients' experience.

Overall, our results confirm that NSC is a practical option for motivated patients who are adequately counselled prior to the procedure. It has the potential to avoid sedation-related complications, particularly in patients with multiple comorbidities, to prevent delay in discharge from hospital, and to allow near immediate return to normal activity. Therefore patient factors alone may not prevent its uptake.
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